Davis Polk advised the underwriter in connection with a block trade of 12,500,000 common shares of Genpact Limited by funds affiliated with Bain Capital Investors, LLC and its co-investor…
Davis Polk advised the joint book-running managers and the lead manager in connection with a $258.8 million public offering of common stock by Portola Pharmaceuticals, Inc. The common stock…
Davis Polk acted as special product counsel to the representatives of the initial purchasers in connection with a Rule 144A offering by Workiva Inc. of $300 million aggregate principal…
Davis Polk advised the initial purchasers in connection with a Rule 144A offering by Insight Enterprises, Inc. of $300 million aggregate principal amount of its 0.750% convertible senior…
Davis Polk advised the forward counterparty in connection with the execution of a forward sale agreement on 7,549,205 shares of Ameren Corporation’s common stock (NYSE: AEE) in connection…
Davis Polk advised Freeport-McMoRan Inc. (“FCX”) in connection with its SEC-registered offering of $1.2 billion of senior notes. The offering consisted of two tranches of senior notes,…
Davis Polk advised the joint lead managers in connection with the Regulation S offering of $80 million principal amount of 11.875% senior notes due 2020 by Yango (Cayman) Investment Limited…
Davis Polk advised the forward purchaser and the forward seller in connection with an at-the-market forward underwriting program for the offer and sale of shares of common stock of Gaming…
Davis Polk advised the sole bookrunner in connection with the $168 million SEC-registered secondary offering of 12,000,000 shares of Class A common stock of Hostess Brands, Inc. by certain…
Davis Polk advised the forward purchasers and forward sellers in connection with an at-the-market forward underwriting program for the offer and sale of shares of common stock of Piedmont…